Rheumatology Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Rheumatology indicates the discipline of internal medicine, including the diagnosis and treatment of rheumatic diseases. Rheumatic diseases are described as the inflammation that affects joints, tendons, bones, ligaments, and sometimes organs. These conditions are also known as musculoskeletal disease, causing deformity, severe pain, and morbidity. The treatment leads to be very costly. Various types of rheumatic diseases with several symptoms are seen all over the world among all age groups.

MARKET DYNAMICS

The rheumatology market is driving due to growth in awareness regarding the early diagnosis and treatment of rheumatology disease symptoms and the increasing use of disease-modifying anti-rheumatic drugs (DMARD's) for treatment of the respective condition. However, the high R&D cost involved in product development will hamper its growth. Moreover, rise in the rate of launches of novel biologics drugs, increasing approvals, and growing penetration of generic medicines is expected to provide opportunities in the global rheumatology market.

MARKET SCOPE

The "Rheumatology Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Rheumatology market with detailed market segmentation by drug class, disease indication, and distribution channel. The rheumatology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in rheumatology market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The rheumatology market is segmented based on drug class, disease indication, and distribution channel. Based on drug class, the market is segmented into nonsteroidal anti-inflammatory drugs (NSAID's), corticosteroids, uric acid drugs, disease modifying anti-rheumatic drugs (DMARD's). Based on disease indication, the market is segmented as rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis. Based on distribution channel, the market is segmented as hospital pharmacy, retail pharmacy, online pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the rheumatology market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rheumatology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Rheumatology market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the rheumatology market in these regions.

MARKET PLAYERS

The report covers key developments in the rheumatology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from rheumatology market are anticipated to have lucrative growth opportunities in the future with the rising demand for rheumatology in the global market. Below mentioned is the list of few companies engaged in the rheumatology market.

The report also includes the profiles of key players in rheumatology market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   AbbVie Inc.
  
•   Bristol-Myers Squibb Company
  
•   Pfizer Inc.
  
•   Merck & Co., Inc.
  
•   Amgen Inc.
  
•   Novartis AG
  
•   Janssen Pharmaceuticals, Inc.
  
•   Sanofi
  
•   Genentech, Inc.
  
•   Takeda Pharmaceutical Company Limited
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Rheumatology Report Scope